Fortrea Holdings (FTRE) Gross Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Gross Margin came in at 20.52% in Q2 2026, up 173.0% YoY from 7.52% in Q2 2025, and up 5.7% on a QoQ basis from 19.42% in Q1 2026.
Fortrea Holdings (FTRE) Gross Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Gross Margin data on file, last reported at 20.52% in Q2 2026.
- Quarterly Gross Margin rose 173.0% year-over-year to 20.52% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 19.3% (down 42.0% YoY) and the FY2025 annual result came in at 18.5%, down 131.0% from the prior year.
- Gross Margin improved to 20.52% in Q2 2026, from 19.42% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 47.27% in Q4 2022 to a low of 16.3% in Q1 2024.
- A 5-year average of 21.65% and a median of 20.52% in 2026 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 2870 bps — and 2026, when it surged 173 bps.
- Tracing FTRE's Gross Margin over 5 years: stood at 47.27% in 2022, then plunged by 61 bps to 18.57% in 2023, then increased by 9 bps to 20.22% in 2024, then retreated by 2 bps to 19.85% in 2025, then increased by 3 bps to 20.52% in 2026.
- The last three Gross Margin figures came in at 20.52% (Q2 2026), 19.42% (Q1 2026), and 19.85% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 20.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.52% |
| Mar 31, 2026 | 19.42% |
| Dec 31, 2025 | 19.85% |
| Sep 30, 2025 | 17.50% |
| Jun 30, 2025 | 18.79% |
| Mar 31, 2025 | 17.89% |
| Dec 31, 2024 | 20.22% |
| Sep 30, 2024 | 21.97% |
| Jun 30, 2024 | 20.70% |
| Mar 31, 2024 | 16.30% |
| Dec 31, 2023 | 18.57% |
| Sep 30, 2023 | 21.01% |
| Jun 30, 2023 | 21.57% |
| Mar 31, 2023 | 21.96% |
| Dec 31, 2022 | 47.27% |
| Sep 30, 2022 | 21.97% |
| Jun 30, 2022 | 22.54% |